Mondelez International, Inc.

WBAG:MDLZ Stock Report

Market Cap: €82.1b

Mondelez International Valuation

Is MDLZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MDLZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MDLZ (€61.75) is trading below our estimate of fair value (€146.05)

Significantly Below Fair Value: MDLZ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MDLZ?

Key metric: As MDLZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MDLZ. This is calculated by dividing MDLZ's market cap by their current earnings.
What is MDLZ's PE Ratio?
PE Ratio22.8x
EarningsUS$3.82b
Market CapUS$86.85b

Price to Earnings Ratio vs Peers

How does MDLZ's PE Ratio compare to its peers?

The above table shows the PE ratio for MDLZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29x
AGR AGRANA Beteiligungs-Aktiengesellschaft
26.3xn/a€684.3m
MAN Josef Manner & Comp
28.2xn/a€194.7m
BN Danone
41.5x18.5%€41.6b
HSY Hershey
20.1x2.7%US$35.6b
MDLZ Mondelez International
22.8x10.6%€86.9b

Price-To-Earnings vs Peers: MDLZ is good value based on its Price-To-Earnings Ratio (22.8x) compared to the peer average (29x).

Price to Earnings Ratio vs Industry

How does MDLZ's PE Ratio compare vs other companies in the European Food Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
MDLZ 22.8xIndustry Avg. 13.4xNo. of Companies18PE0816243240+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MDLZ is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the European Food industry average (13.4x).

Price to Earnings Ratio vs Fair Ratio

What is MDLZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MDLZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MDLZ's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MDLZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€61.75
€76.67
+24.2%
4.6%€87.77€71.55n/a25
Nov ’25€63.36
€74.22
+17.1%
4.4%€84.58€68.96n/a25
Oct ’25€66.37
€72.28
+8.9%
4.5%€79.50€67.76n/a24
Sep ’25€64.41
€70.81
+9.9%
4.8%€79.46€65.91n/a24
Aug ’25€63.14
€72.32
+14.5%
5.5%€81.27€64.65n/a23
Jul ’25€61.30
€75.11
+22.5%
5.0%€84.27€68.35n/a23
Jun ’25€62.54
€74.94
+19.8%
4.2%€82.96€69.14n/a24
May ’25€67.49
€76.24
+13.0%
4.7%€84.18€68.28n/a24
Apr ’25€64.76
€77.36
+19.5%
4.1%€82.86€67.96n/a25
Mar ’25€67.12
€76.79
+14.4%
4.1%€82.13€67.36n/a25
Feb ’25€69.38
€76.08
+9.7%
4.5%€81.88€67.16n/a25
Jan ’25€65.14
€72.97
+12.0%
5.5%€81.08€62.86n/a24
Dec ’24€64.92
€72.17
+11.2%
6.0%€81.11€62.89€61.7523
Nov ’24€63.52
€74.46
+17.2%
7.7%€84.22€61.51€63.3622
Oct ’24€65.90
€78.23
+18.7%
5.4%€84.72€66.63€66.3723
Sep ’24€65.20
€75.73
+16.2%
5.3%€81.58€64.16€64.4121
Aug ’24€67.42
€75.31
+11.7%
5.3%€81.03€63.74€63.1421
Jul ’24€66.80
€73.71
+10.3%
5.2%€78.45€63.85€61.3021
Jun ’24€68.32
€75.21
+10.1%
5.3%€79.86€65.00€62.5421
May ’24€66.16
€72.62
+9.8%
6.4%€78.39€62.89€67.4923
Apr ’24€64.23
€69.45
+8.1%
4.5%€74.62€64.36€64.7623
Mar ’24€60.01
€69.27
+15.4%
4.8%€74.57€61.52€67.1224
Feb ’24€60.63
€67.40
+11.2%
5.1%€72.82€60.08€69.3824
Jan ’24€62.78
€67.95
+8.2%
4.4%€72.54€62.18€65.1424
Dec ’23€64.60
€68.59
+6.2%
3.7%€73.40€63.74€64.9223

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Altria Group

US$97.9b

Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.

ALTR

US$54.38

7D

-0.2%

1Y

39.5%

Südzucker

€2.2b

Produces and sells sugar products in Germany, rest of the European Union, the United Kingdom, the United States, and internationally.

SZU

€10.92

7D

-2.4%

1Y

-22.8%

AGRANA Beteiligungs-Aktiengesellschaft

€684.3m

Operates as an industrial processor of agricultural raw materials in Austria, Hungary, Romania, rest of Europe, and internationally.

AGR

€10.95

7D

-1.4%

1Y

-20.7%